The Federal Trade Commission (FTC) is hosting a workshop on November 8, 2017 at the Constitution Center in Washington, DC entitled: “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.” The workshop will address, among other things, competition for biologics under the BPCIA framework.
The workshop will be free and open to the public, and will also be webcast live. Panelists will be announced at a later date. For more details, click here.
The post Upcoming FTC Workshop: Understanding Competition in Prescription Drug Markets appeared first on Goodwin Procter BioSimilars Blog.